Endometriosis often shows a wide range of symptoms. Some signs include pelvic pain or menstrual irregularities; some patients report symptoms like “silent” endometrosis. Tools like the MyReceptiva test provide a structured way to evaluate underlying factors, and this helps healthcare providers determine unexplained symptoms or fertility challenges. Here’s how an endometriosis test confirms uncommon symptoms:
Misleading Symptoms
Endometriosis involves the uterine lining growing outside the uterus. Some symptoms are not always consistent and vary, and it depends on the individual. Patients may experience digestive issues, chronic fatigue, or worsening discomfort. Symptoms widely range from mild to entirely absent, even when the condition is present. Because these symptoms can resemble other conditions, healthcare providers often begin with a detailed review of medical history. This includes menstrual patterns, other underlying conditions, and overall health. An endometriosis test becomes necessary when symptoms remain unexplained or when standard evaluations do not provide clear answers.
Hiding Indicators
The MyReceptiva test detects a specific protein marker known as BCL6, and this is associated with inflammation in the uterine lining. Elevated levels of this protein link to endometriosis, including cases where the condition is not visible through imaging or other routine exams. To perform the test, a healthcare provider collects a small sample through a biopsy. Professionals analyze the sample to measure for any protein markers. If the BCL6 has high levels, it indicates a strong likelihood that endometriosis exists, even if it has not been previously diagnosed.
This approach allows providers to identify inflammation that may otherwise go undetected. Since BCL6 is typically not found in normal endometrial tissue, its presence needs further evaluation. At MyReceptiva, we offer tests and steps to help individuals learn more about endometriosis and unclear symptoms.
Learning “Silent” Cases
Individuals may not exhibit symptoms associated with endometriosis, but if there is any underlying inflammation, it affects reproductive or overall health. Hidden symptoms include pelvic inflammatory disease, irritable bowel syndrome, or sciatica. Some symptoms are non-specific, and this makes it difficult to diagnose. Symptoms include abdominal discomfort, bloating, pain, urinary urgency, and lower back pain.
The MyReceptiva test helps individuals with unexplained infertility or repeated in vitro fertilization (IVF) failure. Traditional diagnostic methods may not reveal the cause, but elevated BCL6 levels reveal endometriosis as a contributing factor. Research cited by the test provider shows that BCL6 is expressed at high levels in over 90% of women with endometriosis, including those who do not display symptoms. This makes the test a valuable tool for identifying cases that might otherwise remain undiagnosed.
Interpreting Results
A positive result can be confirmed through laparoscopic surgery. This information helps healthcare providers determine whether further evaluation or specialized care is appropriate. Various treatment options help individuals manage the symptoms, and this involves hormone suppression or other pathways to pregnancy. A negative result suggests that endometriosis is unlikely to be the primary cause of symptoms or fertility challenges. Providers can focus on exploring alternative explanations and treatment options. Results should be reviewed thoroughly and taken in context to a complete medical history.
Use an Endometriosis Test
Endometriosis does not always present with clear or typical symptoms. When symptoms are difficult to interpret, targeted testing becomes key, such as testing for BCL6 markers. The MyReceptiva test offers a reliable way to detect inflammation linked to endometriosis. By providing measurable data, it helps confirm whether underlying endometriosis may be contributing to unexplained symptoms or fertility issues. As part of a comprehensive evaluation, this type of testing supports more informed clinical decisions and helps clarify conditions. At MyReceptiva, our team provides a way to test and diagnose this condition related to unexplained infertility.
